T-Cypher Bio
Mapping the immune system to design next-gen therapies
T cells play a central role in many diseases – but we still know little about how they work.
T-Cypher Bio is combining immunopeptidomics, AI and bioinformatics to decode T cell biology and develop novel TCR-based therapies.
Alongside this, they’re building one of the world’s largest immune datasets to enable more precise, personalised treatments for immune-mediated diseases.
Sector
Life Sciences
Stage
- Series A